Literature DB >> 25663074

Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease.

David Justus1, Evelio Perez-Albuerne2, Jacqueline Dioguardi2, David Jacobsohn2, Allistair Abraham2.   

Abstract

Hematopoietic stem cell transplant is curative of sickle cell disease (SCD) but limited by donor availability. Searches for 85 patients with SCD without matched sibling donors from 2009-2013 using modern techniques (allele-level HLA matching for unrelated donors and higher total nucleated cell doses for umbilical cord blood (UCB)) showed potential match probabilities of 20% for 8/8 HLA-matched unrelated donors, 84% for 7/8 donors, and 97% for two 4-6/6 UCBs suitable for ex-vivo expanded/double cord transplant. Searches performed by age 43 months would have a 90% chance of finding a suitable 5-6/6 UCB.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  BMT; sickle cell disease; transplantation

Mesh:

Year:  2015        PMID: 25663074     DOI: 10.1002/pbc.25439

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Allogeneic stem cell transplantation with omidubicel in sickle cell disease.

Authors:  Suhag Parikh; Joel A Brochstein; Einat Galamidi; Aurélie Schwarzbach; Joanne Kurtzberg
Journal:  Blood Adv       Date:  2021-02-09

Review 2.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

3.  Alternative donor hematopoietic stem cell transplantation for sickle cell disease.

Authors:  Andrew L Gilman; Michael J Eckrich; Stacy Epstein; Carrie Barnhart; Mark Cannon; Tracy Fukes; Michelle Hyland; Krishna Shah; Darci Grochowski; Elizabeth Champion; Anastasia Ivanova
Journal:  Blood Adv       Date:  2017-06-28

4.  Are genetic approaches still needed to cure sickle cell disease?

Authors:  Robert A Brodsky; Michael R DeBaun
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.

Authors:  Javier Bolaños-Meade; Kenneth R Cooke; Christopher J Gamper; Syed Abbas Ali; Richard F Ambinder; Ivan M Borrello; Ephraim J Fuchs; Douglas E Gladstone; Christian B Gocke; Carol Ann Huff; Leo Luznik; Lode J Swinnen; Heather J Symons; Stephanie A Terezakis; Nina Wagner-Johnston; Richard J Jones; Robert A Brodsky
Journal:  Lancet Haematol       Date:  2019-03-14       Impact factor: 18.959

Review 6.  Cellular therapy for sickle cell disease.

Authors:  Allistair Abraham; David A Jacobsohn; Catherine M Bollard
Journal:  Cytotherapy       Date:  2016-07-14       Impact factor: 5.414

7.  Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements.

Authors:  Richard A Morgan; Mildred J Unti; Bamidele Aleshe; Devin Brown; Kyle S Osborne; Colin Koziol; Paul G Ayoub; Oliver B Smith; Rachel O'Brien; Curtis Tam; Eric Miyahira; Marlene Ruiz; Jason P Quintos; Shantha Senadheera; Roger P Hollis; Donald B Kohn
Journal:  Mol Ther       Date:  2019-09-28       Impact factor: 11.454

8.  Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease.

Authors:  Antonio Marzollo; Elisabetta Calore; Manuela Tumino; Marta Pillon; Maria Vittoria Gazzola; Roberta Destro; Raffaella Colombatti; Piero Marson; Tiziana Tison; Anna Colpo; Chiara Mainardi; Maria Gabelli; Maria Paola Boaro; Sara Rossin; Aurora Strano; Nadia Quaglia; Federica Menzato; Giuseppe Basso; Laura Sainati; Chiara Messina
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-02-15       Impact factor: 2.576

9.  Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy.

Authors:  Adetola A Kassim; Alexis Leonard
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.